All News

From measles resurgence to new CVD guidelines, refresh your memory of this year’s highlights with our quiz on the most-read content on Patient Care®.

Try these 7 questions on guideline-oriented cystic fibrosis diagnosis and treatment.

Is there an attitude problem about obesity?

Is Santa's lifestyle good for his health? Scroll through this quick slideshow for a deeper look at how 5 of his habits, both naughty and nice, impact his health.

The NEJM Knowledge+ Internal Medicine Review app, a flashcard app from the American College of Physicians, and 3 more apps that can help busy physicians ace any board exam.

ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.

RELAX: The right gift is out there--as proof, Patient Care has collected 10 more ideas for medical merry-making that range from serious to silly. Enjoy!

Check out the good, the bad, and the ugly side of the holiday season and how it impacts the overall well-being of both physicians and patients. 

A 44-year-old man arrives at the ED via ambulance complaining of knee pain and inability to bend or fully straighten his left leg. He had been in a wrestling competition. 

From healthy eating patterns to keeping that feast safe to eat, offer patients these 8 tips to kick off a healthier holiday season.

Cardiovascular outcomes trials of diabetes drugs have led to label expansions and guideline endorsements. Do you recall the studies and the outcomes? Find out, here.

These 6 recommendations from the CDC can aid physicians in differential diagnosis and treatment of EVALI and the flu. 

AHA 2019 ICYMI: Summaries of 11 late-breaking clinical trials presented at the 2019 Scientific Sessions held in Philadelphia, PA, Nov 16-18.

Highlights of an evidence-based review offer practical guidance for effective depression screening and assessment strategies for primary care physicians.

Sample: What tobacco product was most commonly used among US adults in 2018? E-cigarettes? Traditional cigarettes? Neither? The answer may surprise.

AHA Scientific Sessions 2019: Post-TAVR use of rivaroxaban is not recommended for routine use among patients with no indication for anticoagulation.

AHA Scientific Sessions 2019: Semi-annual injection of the novel agent inclisiran in the ORION-10 trial decreased LDL-C by 56% in patients with ASCVD on maximal statin therapy.

AHA Scientific Sessions 2019: Early results from the EVAPORATE study suggest promise for icosapent ethyl as add-on therapy in patients with high TGs already taking statins.